OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Gastroenterology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Small varices in chronic liver diseases	64
Hepatitis E virus: has anything changed?	34
Medical malpractice and gastrointestinal endoscopy	33
Editorial introductions	31
Updates and innovations in therapeutic endoscopy	30
Editorial introductions	29
Clostridioides difficile infections; new treatments and future perspectives	27
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	27
Cholangioscopy for biliary diseases	25
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	25
Using nutrition to help recovery from infections	21
Stomach and duodenum: what's current in 2023	18
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	18
Editorial introductions	16
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	16
Current and future microbiome-based therapies in inflammatory bowel disease	16
Carnitine derivatives beyond fatigue: an update	15
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	15
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	14
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	14
Prognostic modeling in biliary diseases	13
Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	13
The gut virome in health and disease: new insights and associations	13
COVID-19 vaccine-induced liver injury	13
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	13

Considerations when starting patients on multiple biologics and small molecules	13
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	12
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	12
Clinical and translational markers of severity and prognosis in chronic pancreatitis	12
Endoscopic management of colonic perforations	11
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	11
Gastric submucosal mass lesions	11
Implications of Paneth cell dysfunction on gastrointestinal health and disease	11
Endoluminal bariatric and metabolic therapies: state-of-the-art	11
Gastroparesis: time for a paradigm change	11
Ergonomic wellness for the trainee in gastrointestinal endoscopy	11
Role of albumin in the treatment of decompensated liver cirrhosis	11
Nutritional aspects in patients with gastroparesis	10
Celiac disease and nonceliac enteropathies	10
Bidirectional relationship between acute pancreatitis and pancreatic cancer	10
Artificial intelligence within the small bowel: are we lagging behind?	10
Machine and deep learning in inflammatory bowel disease	10
Advances in the evaluation and treatment of autoimmune hepatitis	10
Histological evaluation in biliary diseases	10
Tight junction proteins and biliary diseases	10
Bile acid diarrhea – as bad as it gets?	9
Managing the older adult with inflammatory bowel disease: is age just a number?	9
Endoscopic approaches to the management of hemorrhoids	9
Diagnosis and management of acute lower gastrointestinal bleeding	9
Editorial introductions	9
Advances in endoscopic management of colonic diverticular bleeding	9
Updates on therapeutic endoscopic ultrasound	8
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	8
Intestinal proteases	8
Updates in endoscopic management of ampullary and duodenal adenomas	8
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	8
The rise of antibiotic resistance in Campylobacter	8
Endoscopic approaches to small intestinal strictures	8
Alterations in microbiome associated with acute pancreatitis	8
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	7
Editorial introductions	7
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	7
Intestinal transplantation: an update	7
Pathophysiology updates: gastroduodenal injury and repair mechanisms	7
The spectrum of diabetes in acute and chronic pancreatitis	7
The status of endoscopic therapies for gastroesophageal reflux disease	7
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	7
Editorial: Advances in hepatology: 2022	7
Diet and carcinogenesis of gastric cancer	7
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	7
Neurological disorders and small bowel dysmotility	6
Editorial introductions	6
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	6
Management of refractory inflammatory bowel disease	6
Editorial: The next-generation toolkit for exploring biliary diseases	6

Bulking agents in gastrointestinal endoscopy: present applications and future advances	6
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	6
The use of artificial intelligence in colonoscopic evaluations	6
Editorial introductions	6
Advances in colon-targeted drug technologies	6
Update on extraesophageal manifestations of gastroesophageal reflux	6
Editorial introductions	6
Small bowel intussusception – aetiology & management	5
Editorial: Stomach and duodenum: what is current in 2022?	5
The vermiform cecal appendix, expendable or essential? A narrative review	5
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities	5
Interpretation of serum pancreatic enzymes in pancreatic and nonpancreatic conditions	5
Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?	5
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps	5
A ramble through the small bowel	5
Role of endoscopy on enteral feeding	5
Editorial: The future of inflammatory bowel disease management	5
Retention of small bowel capsule endoscopy	5
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis	5
Small bowel Crohn's disease: optimal modality for diagnosis and monitoring	5
Targeting osteopontin to treat primary sclerosing cholangitis	5
The role of the microbiome in liver disease	5
Immune markers of severe acute pancreatitis	5
Editorial introduction	5
Bile acids as metabolic regulators: an update	4
The evaluation of liver abnormalities in inflammatory bowel disease patients	4
Imaging of the biliary tract	4
Population level screening for celiac disease: is now the time?	4
Neuro-immune cell interactions in the regulation of intestinal immune homeostasis	4
Clostridium difficile in inflammatory bowel disease	4
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management	4
Small intestinal bacterial overgrowth: current update	4
Mast cell activation and nutritional disorders in patients with hypermobility	4
Update on pain management in acute pancreatitis	4
A Practical guide to selecting and using new Crohn's disease therapies	4
Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease	4
Editorial: Pathology in the small bowel – challenges, trials and tribulations	4
Road map to small bowel endoscopy quality indicators	4
Macrophages in cholangiopathies	4
The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma	4
Noninvasive evaluation of fibrosis in adult biliary diseases	3
Small bowel obstruction: what a gastroenterologist needs to know	3
Editorial introductions	3
Editorial: food, nutrition and the microbiome in health and disease	3
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?	3
A practical guide to selecting and using new ulcerative colitis therapies	3
Lichen planus esophagitis	3
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	3
Editorial: The fight against infectious diseases begins anew	3
Drug-induced bile duct injury: new agents, new mechanisms	3
Editorial introductions	3
Cellular senescence in the cholangiopathies	3
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	3
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	3
Endobariatrics: well past infancy and maturing rapidly	3
The use of ultrasound in colonic and perianal diseases	3
Integrins in biliary injury and fibrosis	3
Editorial introductions	3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors	3
Selection of endoscopic resection technique for large colorectal lesion treatment	3
Colon polyps: updates in classification and management	3